524717 TITANBIO

Titan Biotech Share Price

₹767.00 +10 (1.32%)

24 Nov, 2024 02:46

SIP TrendupStart SIP in TITANBIO

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month -18.08%
  • Over 3 Month + 28.36%
  • Over 6 Month + 38.34%
  • Over 1 Year + 78.46%
SIP Lightning

Smart Investing Starts Here Start SIP with Titan Biotech for Steady Growth!

Invest Now

Titan Biotech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Titan Biotech Financials

Titan Biotech Technicals

EMA & SMA

Current Price
₹767.00
+ 10 (1.32%)
pointer
  • stock-down_img
  • Bullish Moving Average 5
  • stock-up_img
  • Bearish Moving Average 11
  • 20 Day
  • ₹831.25
  • 50 Day
  • ₹793.86
  • 100 Day
  • ₹722.94
  • 200 Day
  • ₹632.04

Resistance and Support

757.98 Pivot Speed
  • R3 802.77
  • R2 785.33
  • R1 775.42
  • S1 748.07
  • S2 730.63
  • S3 720.72

What's your outlook on Titan Biotech?

You can only vote for once

Titan Biotech Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-12 Quarterly Results
2024-08-13 Quarterly Results
2024-05-29 Audited Results
2024-02-12 Quarterly Results
2023-11-08 Quarterly Results

Titan Biotech F&O

Titan Biotech Shareholding Pattern

No data available.

About Titan Biotech

  • NSE Symbol
  • TITANBIO
  • BSE Symbol
  • 524717
  • ISIN
  • INE150C01011

Similar Stocks to Titan Biotech

Titan Biotech FAQs

Titan Biotech share price is ₹767 As on 24 November, 2024 | 02:32

The Market Cap of Titan Biotech is ₹633.8 Cr As on 24 November, 2024 | 02:32

The P/E ratio of Titan Biotech is 25.1 As on 24 November, 2024 | 02:32

The PB ratio of Titan Biotech is 4.7 As on 24 November, 2024 | 02:32

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23